Metastatic Renal Cell Carcinoma ( mRCC)
Oncology
Prevalence
30.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Metastatic Renal Cell Carcinoma ( mRCC)?
There are 1 clinical trial targeting Metastatic Renal Cell Carcinoma ( mRCC) tracked by BioSniper.
What is the prevalence of Metastatic Renal Cell Carcinoma ( mRCC)?
The estimated prevalence of Metastatic Renal Cell Carcinoma ( mRCC) is approximately 30.0 per 100,000 population.
Deep-dive into Metastatic Renal Cell Carcinoma ( mRCC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis